LEXX - Lexaria Bioscience Corp logo

LEXX

Lexaria Bioscience Corp

Lexaria Bioscience Corp develops DehydraTECH, a patented drug delivery technology that enhances the absorption of active pharmaceutical ingredients using long-chain fatty acids. Its applications span various therapeutic areas and product formats, including pharmaceuticals and nutraceuticals.

โš•๏ธ Healthcare NASDAQ Listed 2006 $ USD
$1,000 invested 5 years ago โ†’$73today

Score Overview

1 Year
Score
Net Growth19.93%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-47.87%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.6
Net Growth-136.65%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-49.08%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-5x
Net Trend50%
Net Income Consistency
Rev Growth9x
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-7x
Net Trend58%
Net Income Consistency
Rev Growth-59.15%
Rev Trend47%
Revenue Consistency

See the full market ranking โ†’

Lexaria Bioscience Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 314.79K to $ 705.92K and net income went from -$ 3M to -$ 11M. Revenue increased in 2 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 14.7K to $ 705.92K and net income went from -$ 1M to -$ 11M. Revenue increased in 6 of those 10 years; net income in 5.

Lexaria Bioscience Corp currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.12โ€”
1 Year2025-08-12
$ 12.51-51.08%
5 Years2021-08-12
$ 83.85-92.70%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 368K-$ 9M$ 5M
2025$ 705.92K-$ 11M$ 1M
2024$ 464.28K-$ 5M$ 6M
2023$ 226.21K-$ 6M$ 1M
2022$ 255.4K-$ 7M$ 6M
2021$ 722.74K-$ 4M$ 11M
2020$ 314.79K-$ 3M$ 1M
2019$ 222.61K-$ 4M$ 1M
2018$ 433.29K-$ 6M$ 1M
2017$ 63.64K-$ 1M$ 2M
2016$ 40.72K-$ 1M$ 93.41K
2015$ 14.7K-$ 1M$ 260.07K
2014$ 1M-$ 1M$ 65.54K
2013$ 1M-$ 343.55K$ 65.54K
2012$ 1M-$ 343.55K$ 27.53K
2011$ 1M-$ 251.51K$ 31.2K
2010$ 1M-$ 538.23K$ 494.44K
2009$ 362.47K-$ 552.46K$ 431.39K
2008$ 421.95K-$ 753.57K$ 239.66K
2007$ 900.79K-$ 978.49K$ 78.06K

Explore beyond LEXX

You're looking at Lexaria Bioscience Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies